Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.2K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

301
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
301
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

378
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
378
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

314
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
314
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

50
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
50
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

684
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
684

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026
Same author

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing Changes.

Statistics in medicine·2026
Same author

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Precision generalized phase I-II designs.

Biometrics·2025
Same author

Practical Bayesian Guidelines for Small Randomized Oncology Trials.

Cancers·2025

Related Experiment Video

Updated: Mar 9, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Bayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition Times.

Yanxun Xu1, Peter Müller2, Abdus S Wahed3

  • 1Division of Statistics and Scientific Computing, The University of Texas at Austin, Austin, TX.

Journal of the American Statistical Association
|December 27, 2016
PubMed
Summary

This study introduces a novel Bayesian nonparametric survival model for dynamic treatment regimes in acute leukemia clinical trials. The new method, DDP-GP, significantly improves inference accuracy over existing approaches for personalized cancer treatment strategies.

Keywords:
Dependent Dirichlet processG-ComputationGaussian processIn-verse probability of treatment weightingMarkov chain Monte Carlo

More Related Videos

A Tactile Automated Passive-Finger Stimulator TAPS
19:44

A Tactile Automated Passive-Finger Stimulator TAPS

Published on: June 3, 2009

14.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Related Experiment Videos

Last Updated: Mar 9, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
A Tactile Automated Passive-Finger Stimulator TAPS
19:44

A Tactile Automated Passive-Finger Stimulator TAPS

Published on: June 3, 2009

14.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Oncology

Background:

  • Acute leukemia treatment involves complex multi-stage chemotherapy regimes.
  • Standard clinical trial designs may not fully capture the impact of adaptive treatment strategies on survival.
  • Dynamic treatment regimes (DTRs) offer a framework to model sequential, personalized treatment decisions.

Purpose of the Study:

  • To develop and evaluate a Bayesian nonparametric survival model for analyzing dynamic treatment regimes in acute leukemia.
  • To assess the impact of sequential salvage treatments on overall survival time.
  • To compare the proposed model's performance against existing methods like inverse probability of treatment weighting.

Main Methods:

  • Utilized a dataset from a 2x2 factorial clinical trial for frontline therapies in acute leukemia.
  • Modeled therapy as a dynamic treatment regime (DTR), incorporating adaptive treatments and disease state transitions.
  • Employed a Bayesian nonparametric survival regression model with a dependent Dirichlet process prior and Gaussian process base measure (DDP-GP).
  • Implemented posterior simulation using Markov chain Monte Carlo (MCMC) sampling.

Main Results:

  • The proposed DDP-GP Bayesian nonparametric approach demonstrated substantial improvements in inference compared to traditional methods.
  • Simulations showed the model's effectiveness in handling both single-stage and multi-stage treatment regimes.
  • The method accurately accounts for how subsequent salvage treatments influence patient survival time.

Conclusions:

  • The DDP-GP model provides a powerful and flexible framework for analyzing dynamic treatment regimes in complex clinical trial settings.
  • This approach enhances the understanding of personalized treatment strategies and their impact on survival outcomes in acute leukemia.
  • Freely available R software facilitates the implementation of this advanced Bayesian nonparametric analysis.